205 related articles for article (PubMed ID: 18019596)
1. [Microbiology of urinary tract infections in ambulatory patients. Therapeutic options in times of high antibiotic resistance].
Arreguín V; Cebada M; Simón JI; Sifuentes-Osornio J; Bobadilla-del Valle M; Macías AE
Rev Invest Clin; 2007; 59(4):239-45. PubMed ID: 18019596
[TBL] [Abstract][Full Text] [Related]
2. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
[TBL] [Abstract][Full Text] [Related]
4. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal.
Sire JM; Nabeth P; Perrier-Gros-Claude JD; Bahsoun I; Siby T; Macondo EA; Gaye-Diallo A; Guyomard S; Seck A; Breurec S; Garin B
J Infect Dev Ctries; 2007 Dec; 1(3):263-8. PubMed ID: 19734603
[TBL] [Abstract][Full Text] [Related]
6. Etiologies of the urinary tract infections in a Yemeni City.
Nasher MA; Nasher TM; Gunaid AA
Saudi Med J; 2001 Jul; 22(7):599-602. PubMed ID: 11479641
[TBL] [Abstract][Full Text] [Related]
7. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
Akyar I
Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
[TBL] [Abstract][Full Text] [Related]
8. [Short communication: comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and different antibiotics].
Aykut Arca E; Karabiber N
Mikrobiyol Bul; 2007 Jan; 41(1):115-9. PubMed ID: 17427560
[TBL] [Abstract][Full Text] [Related]
9. Frequency and susceptibility profile of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal.
Das RN; Chandrashekhar TS; Joshi HS; Gurung M; Shrestha N; Shivananda PG
Singapore Med J; 2006 Apr; 47(4):281-5. PubMed ID: 16572238
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiology and pathogen spectrum of urinary tract infections].
Breyer S; Feistauer SM; Burgmann H; Georgopoulos M; Georgopoulos A
Wien Med Wochenschr; 1991; 141(23-24):533-6. PubMed ID: 1810091
[TBL] [Abstract][Full Text] [Related]
11. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
[TBL] [Abstract][Full Text] [Related]
12. Multi-drug resistance of Escherichia coli from the urinary tract.
Rafay AM; Nsanze HN
Saudi Med J; 2003 Mar; 24(3):261-4. PubMed ID: 12704500
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of Escherichia coli strains isolated from outpatient children with community-acquired urinary tract infection in southern Switzerland.
Borsari AG; Bucher B; Brazzola P; Simonetti GD; Dolina M; Bianchetti MG
Clin Ther; 2008 Nov; 30(11):2090-5. PubMed ID: 19108796
[TBL] [Abstract][Full Text] [Related]
14. [High incidence of resistant pathogens in community acquired bacteriuria from patients in the Jerusalem area with lower urinary tract infections].
Abdul-Ghani MA; Glicberg F; Sahagian H
Harefuah; 2002 Dec; 141(12):1032-5, 1091, 1090. PubMed ID: 12534199
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes.
Ho PL; Wong RC; Yip KS; Loke SL; Leung MS; Mak GC; Chow FK; Tsang KW; Que TL;
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):439-45. PubMed ID: 17888610
[TBL] [Abstract][Full Text] [Related]
16. Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections.
Pullukcu H; Tasbakan M; Sipahi OR; Yamazhan T; Aydemir S; Ulusoy S
Int J Antimicrob Agents; 2007 Jan; 29(1):62-5. PubMed ID: 17189097
[TBL] [Abstract][Full Text] [Related]
17. [Distribution and resistance trends of pathogens from urinary tract infections and impact on management].
Shao HF; Wang WP; Zhang XW; Li ZD
Zhonghua Nan Ke Xue; 2003 Dec; 9(9):690-2, 696. PubMed ID: 14727361
[TBL] [Abstract][Full Text] [Related]
18. Urinary tract infections in Norway: bacterial etiology and susceptibility. A retrospective study of clinical isolates.
Grude N; Tveten Y; Kristiansen BE
Clin Microbiol Infect; 2001 Oct; 7(10):543-7. PubMed ID: 11683794
[TBL] [Abstract][Full Text] [Related]
19. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
[TBL] [Abstract][Full Text] [Related]
20. Bacterial profile and drug susceptibility pattern of urinary tract infection in pregnant women at Tikur Anbessa Specialized Hospital Addis Ababa, Ethiopia.
Assefa A; Asrat D; Woldeamanuel Y; G/Hiwot Y; Abdella A; Melesse T
Ethiop Med J; 2008 Jul; 46(3):227-35. PubMed ID: 19271386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
